A group of patients developed eye inflammation after receiving treatment at Tangier University Hospital in early October 2026. According to the Tangier-Tetouan-Al Hoceima Health Group, medical interventions have controlled the infection and alleviated eye inflammation. The group reported on November 9 that medical evaluations showed varying degrees of visual improvement and stability among patients, while others require continued medical monitoring and specialized care.
Five patients have been discharged from the hospital and are being followed up through medical consultations, while ten patients remain under care within the hospital. Medical teams confirm that recovery is progressing gradually and that the final evaluation depends on the development of the condition, completion of treatment, and a follow-up period that may extend to around two months. An investigation has been launched by the Ministry of Health and Social Protection to determine the circumstances surrounding the incident.
The investigation involves a committee for inspection and investigation, which is still preparing its report pending completion of necessary analyses and examinations. The investigation includes studying the products concerned, their storage and preparation conditions, and their handling by the relevant staff, as well as examining the premises, tools, and means used. The medical data and technical aspects related to the incident are also being examined.
The Tangier-Tetouan-Al Hoceima Health Group emphasizes that the conclusions of the investigation will be announced according to the applicable procedures and that responsibilities will be determined and administrative and legal measures will be taken in light of the findings. The hospital's management had previously announced on October 13, 2026, that it had detected acute inflammation cases in patients who had benefited from medical treatment in the ophthalmology department.
The treatment was administered on October 8, 2026, and the first cases were recorded on October 9. Upon registration, medical teams took necessary preventive measures and contacted all patients who had received the same treatment, inviting them to undergo additional medical examinations to ensure their safety. The examinations conducted on October 10 revealed similar inflammations in 13 patients out of 16.
The hospital's management stated that all concerned patients received appropriate care and continuous medical monitoring under the supervision of a specialized medical team. The management also initiated procedures for medical and technical investigation to determine the possible causes of these inflammations and take necessary measures according to adopted health standards.
The hospital's management emphasized that patient health and safety remain a top priority and reiterated its commitment to providing necessary medical care and continuing to closely monitor the cases concerned. The management also assured that it will keep the public informed of related developments within the framework of transparency and responsibility.
Key points
- Medical interventions control infection, alleviate eye inflammation in patients treated at Tangier hospital
- Investigation launched to determine circumstances surrounding eye inflammation incident
- Patients' health and safety remain top priority, hospital management assures continued care and transparency
